Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal while Fenwick & West represented Lycia Therapeutics. Lycia Therapeutics, Inc., a leader in extracellular protein...
Lycia Therapeutics’ $70 Million Series B Financing
Vigil Neuroscience’s $90 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience. Vigil Neuroscience, a biotechnology company harnessing the power of...
Forge Biologics’ $120 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the closing of...
Alussa Energy’s Business Combination Agreement With Freyr AS
Wiersholm and Elvinger Hoss Prussen assisted Alussa Energy on the deal while Wilson Sonsini Goodrich & Rosati and Arendt have advised FREYR AS on the deal....